Eli Lilly and Company

The hub expands the company's research and development footprint in the region and hastens the development of AI-powered digital health technologies.

The collaboration will leverage Genetic Leap's RNA-targeted AI platform to create genetic medicines against selected targets.  

Also: Sutter Health and Aetna's joint venture partners with house call startup Heal; SideKickHealth announces strategic partnership with Bayer.

Pharma companies also continued to explore the promises of digital therapeutics. 

Onduo, Livongo, Abbott and others also shared news at the show.

Also: Case Western Reserve University's rowing team will now wear VivaLNK's wearable patches and Memorial Sloan Kettering Cancer Center inks a deal with MyHealthDirect. 

Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon, which is designed to help caregivers and providers treat people with diabetes if they fall into an insulin coma.

San Diego, California-based Companion Medical, a stealthy medical device startup developing a Bluetooth-connected insulin pen and connected app, has closed its second round of funding, led by Eli Lilly and Company.

When it comes to digital health, pharmaceutical companies tend to be slow and cautious, because of the onerous risks they face from the FDA should they improperly market a drug via the internet or mobile channels.